- $1.31bn
- $1.22bn
- $23.07m
Annual balance sheet for Enovix, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2020 December 31st | 2022 January 2nd | 2023 December 31st | 2023 January 1st | 2024 December 29th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 29.1 | 385 | 307 | 323 | 273 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 2.42 | 0.17 | 4.57 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 33 | 398 | 323 | 330 | 295 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 31.3 | 83.3 | 182 | 110 | 181 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 65 | 483 | 564 | 441 | 527 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.9 | 20.6 | 61 | 23 | 53.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 28.7 | 156 | 306 | 84.2 | 280 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 36.2 | 326 | 258 | 356 | 247 |
Total Liabilities & Shareholders' Equity | 65 | 483 | 564 | 441 | 527 |
Total Common Shares Outstanding |